Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Assets Average (2022 - 2026)

Tevogen's (TVGN) quarterly Assets Average came in at $4.7 million in Q1 2026, up 23.48% on a YoY basis from $3.8 million in Q1 2025, and up 4.81% quarter-over-quarter from $4.4 million in Q4 2025.

Analysis

Tevogen (TVGN) Assets Average (2022 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Assets Average for 5 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Assets Average rose 23.48% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (up 23.48% YoY), and the FY2025 full-year result was $3.9 million, down 12.52% from the prior year.
  • Assets Average improved to $4.7 million in Q1 2026 per TVGN's latest filing, from $4.4 million in the prior quarter.
  • Across five years, Assets Average topped out at $355.8 million in Q4 2022 and bottomed at $3.3 million in Q2 2024.
  • Historically, Assets Average has averaged $100.7 million across 5 years, with a median of $4.7 million in 2026.
  • The sharpest annual moves came in 2024 and 2025: Assets Average sank 97.68% in 2024, then gained 25.0% in 2025.
  • Over 5 years, Assets Average stood at $355.8 million in 2022, then sank by 95.52% to $16.0 million in 2023, then sank by 75.71% to $3.9 million in 2024, then grew by 14.52% to $4.4 million in 2025, then grew by 4.81% to $4.7 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $4.7 million, $4.4 million, and $4.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 1.45 Bn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 2.69 Bn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 920.60 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 1.67 Bn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 881.90 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 1.43 Bn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 154.46 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 3.18 Bn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 494.25 Mn
10 Tevogen 27.76 Mn 27.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.65 Mn
Dec 31, 2025 4.44 Mn
Sep 30, 2025 4.38 Mn
Jun 30, 2025 4.17 Mn
Mar 31, 2025 3.77 Mn
Dec 31, 2024 3.88 Mn
Sep 30, 2024 3.80 Mn
Jun 30, 2024 3.34 Mn
Mar 31, 2024 4.43 Mn
Dec 31, 2023 15.96 Mn
Sep 30, 2023 26.39 Mn
Jun 30, 2023 25.92 Mn
Mar 31, 2023 191.30 Mn
Dec 31, 2022 355.84 Mn
Sep 30, 2022 353.76 Mn
Jun 30, 2022 352.90 Mn
Mar 31, 2022 352.84 Mn